-
1
-
-
0032522873
-
Incidence of adverse drug reactions in hospitalized patients: A meta- analysis of prospective studies
-
DOI 10.1001/jama.279.15.1200
-
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-1205 (Pubitemid 28193431)
-
(1998)
Journal of the American Medical Association
, vol.279
, Issue.15
, pp. 1200-1205
-
-
Lazarou, J.1
Pomeranz, B.H.2
Corey, P.N.3
-
2
-
-
0034949062
-
Identifying hospital admissions due to adverse drug events using a computer-based monitor
-
DOI 10.1002/pds.568
-
Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10(2): 113-119 (Pubitemid 32590942)
-
(2001)
Pharmacoepidemiology and Drug Safety
, vol.10
, Issue.2
, pp. 113-119
-
-
Jha, A.K.1
Kuperman, G.J.2
Rittenberg, E.3
Teich, J.M.4
Bates, D.W.5
-
4
-
-
84887245433
-
Activation of drug adverse event spontaneous reporting
-
(Korean)
-
Park BJ. Activation of drug adverse event spontaneous reporting. J Korean Med Assoc 2002; 45(11): 1274-1279 (Korean)
-
(2002)
J Korean Med Assoc
, vol.45
, Issue.11
, pp. 1274-1279
-
-
Park, B.J.1
-
5
-
-
0032444841
-
Re-examination system for new drugs in Korea
-
(Korean)
-
Park BJ. Re-examination system for new drugs in Korea. J Korean Soc Clin Pharmacol 1998; 6(1): 3-15 (Korean)
-
(1998)
J Korean Soc Clin Pharmacol
, vol.6
, Issue.1
, pp. 3-15
-
-
Park, B.J.1
-
6
-
-
0030497852
-
Regulatory pharmacovigilance in the United Kingdom: Current principles and practice
-
DOI 10.1002/(SICI)1099-1557(199611)5:6 <363::AID-PDS249>3.0.CO;2-7
-
Waller PC, Coulson RA, Wood SM. Regulatory pharmacovigilance in the United Kingdom: Current principles and practice. Pharmacoepidemiol Drug Saf 1996; 5(6): 363-375 (Pubitemid 27062318)
-
(1996)
Pharmacoepidemiology and Drug Safety
, vol.5
, Issue.6
, pp. 363-375
-
-
Waller, P.C.1
Coulson, R.A.2
Wood, S.M.3
-
7
-
-
0037275431
-
A model for the future conduct of pharmacovigilance
-
DOI 10.1002/pds.773
-
Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003; 12(1): 17-29 (Pubitemid 36192946)
-
(2003)
Pharmacoepidemiology and Drug Safety
, vol.12
, Issue.1
, pp. 17-29
-
-
Waller, P.C.1
Evans, S.J.W.2
-
8
-
-
24344486667
-
Data mining in pharmacovigilance: The need for a balanced perspective
-
DOI 10.2165/00002018-200528100-00001
-
Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: The need for a balanced perspective. Drug Saf 2005; 28(10): 835-842 (Pubitemid 41428541)
-
(2005)
Drug Safety
, vol.28
, Issue.10
, pp. 835-842
-
-
Hauben, M.1
Patadia, V.2
Gerrits, C.3
Walsh, L.4
Reich, L.5
-
9
-
-
84887243177
-
-
Food and Drug Administration (FDA). Public Law 105-115 [cited 2007 Jun 15]
-
Food and Drug Administration (FDA). FDA Moderization Act of 1997. Public Law 105-115 [cited 2007 Jun 15]; Available from: URL:http: //www.fda.gov/cder/ guidance/105-115.htm
-
FDA Moderization Act of 1997
-
-
|